Doximity Shares Fall 7% After Lower Revenue Guidance [MarketWatch]
Doximity, Inc. Class A (DOCS)
Company Research
Source: MarketWatch
At 12:31 p.m. ET, the company's shares were trading 7.5% lower at $37.27 each. Volume at the time topped 4.5 million shares, above the stock's 65-day average of some 2.4 million shares. After the bell Thursday, Doximity reported first-quarter earnings per share of 10 cents on revenue of $90.6 million. In the year-ago period, the company reported earnings per share of 9 cents on revenue of $72.7 million. The company also cut its fiscal-year revenue guidance to a range between $424 million and $432 million from a previous guidance of $454 million to $458 million. On Friday, Piper Sandler cut its price target on Doximity's stock to $39 a share from $44, B of A Securities slashed its price target to $29 a share from $43 and Canaccord Genuity lowered its target to $42 a share from $47, as reported by Benzinga. Doximity offers a digital platform for U.S. medical professionals. Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024Business Wire
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) InvestorsBusiness Wire
- DOCS Announcement: Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Doximity, Inc.Accesswire
- DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmAccesswire
- Doximity, Inc. (NASDAQ: DOCS) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $25.00 price target on the stock.MarketBeat
DOCS
Earnings
- 2/8/24 - Beat
DOCS
Sec Filings
- 4/2/24 - Form 4
- 4/1/24 - Form 144
- 3/4/24 - Form 4
- DOCS's page on the SEC website